UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):November 20, 2026

 

TOTALIGENT, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-41803

 

80-0142655

(State or other

jurisdiction of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

3651 FAU Boulevard, Suite 400

Boca Raton, Florida

(Address of principal executive offices)

 

33431

(Zip Code)

 

Registrant’s telephone number, including area code: (561) 360-3565

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities Registered Pursuant to Section 12(b) of the Act:

 

Title of Each Class

Trading Symbol(s)

Name of Each Exchange on Which Registered

N/A

N/A

N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 

 

 

 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On November 20, 2026, Edward C. DeFeudis tendered his resignation from every office, directorship, and other position he holds with Totaligent, Inc., a Delaware corporation (the “Company”), including, without limitation, his positions as Chairman of the Board, Director, Chief Executive Officer, President, Chief Financial Officer, Principal Executive Officer, Principal Financial Officer, and Principal Accounting Officer, and any committee appointment. The resignation is effective as of 5:00 p.m. Eastern Standard Time on November 20, 2026 (the “Effective Time”).

 

On the Effective Time, Mr. DeFeudis will have no remaining office, directorship, employment, consulting arrangement, or other service relationship with the Company. This resignation does not transfer, surrender, or otherwise affect any shares or other securities of the Company that Mr. DeFeudis beneficially owns.

 

Mr. DeFeudis’ resignation is not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.

 

Also on November 20, 2026, the Board of Directors of the Company, by unanimous written consent, accepted Mr. DeFeudis’ resignation effective as of the Effective Time and appointed Brian Heckathorne as Chairman of the Board, Chief Executive Officer, President, Chief Financial Officer, Principal Executive Officer, Principal Financial Officer, and Principal Accounting Officer of the Company, effective as of the Effective Time. Mr. Heckathorne previously served as a Director of the Company.

 

In addition, the Board appointed Tyler Wilson as a Director of the Company, effective as of the Effective Time.

 

There are no arrangements or understandings between Mr. Heckathorne or Mr. Wilson and any other person pursuant to which they were selected as officers or directors, other than their appointment by the Board. Neither Mr. Heckathorne nor Mr. Wilson has any family relationship with any director or executive officer of the Company, and neither has been involved in any transaction with the Company that would be required to be disclosed pursuant to Item 404(a) of Regulation S-K.

 

 

2

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

TOTALIGENT, INC.

 

 

 

 

 

Date: November 20, 2026

By:

/s/ Edward C. DeFeudis

 

 

 

Edward C. DeFeudis

 

 

 

Chairman and Chief Executive Officer

 

 

 

3